2C-G-3
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2C-G-3, also known as 2,5-dimethoxy-3,4-(trimethylene)phenethylamine, is a psychedelic drug of the phenethylamine and 2C families.[1] It is the derivative of 2C-G (2C-G-0) in which the 3,4-dimethyl groups have been connected via an additional carbon atom to form a cyclopentane ring attached to the benzene ring and hence has a dihydroindene ring system.[1]
- None
 | |
| Clinical data | |
|---|---|
| Other names | 2,5-Dimethoxy-3,4-(trimethylene)phenethylamine; 3,4-Trimethylene-2,5-dimethoxyphenethylamine; 3,4-Trimethylene-2,5-DMPEA |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 12–24 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H19NO2 |
| Molar mass | 221.300 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
In his 1991 book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 2C-G-3's dose as 16 to 25 mg orally and its duration as 12 to 24 hours.[1][2][3] The effects of 2C-G-3 were reported to include "lots of LSD-like sparkles", easier communication, impairment, and social avoidance, among others.[1] One report remarked that it was "marvelous".[1]
The chemical synthesis of 2C-G-3 has been described.[1]
The drug was first described in the literature by Shulgin in PiHKAL in 1991.[1] It is a controlled substance in Canada under phenethylamine blanket-ban language.[4]